ArticleMolecular neurobiology2025
Huang Lian Jie Du Decoction Prevents Chronic Alcoholic Encephalopathy and Improves Gut Microbiota Imbalance in Mice.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Huang Lian Jie Du Decoction (HLJDD) has anti-inflammatory, immunomodulatory, intestinal flora regulation, and anticoagulant effects, but the effects and mechanisms of HLJDD on chronic alcoholic encephalopathy (CAE) remain unclear. This study aimed to investigate the effect and mechanism of HLJDD to improve CAE. CAE mouse model was established, and the mice were treated with different doses of HLJDD according to the principle of randomized controlled trial. Open field test and Morris water maze were used to observe the locomotor and learning memory abilities of mice, hematoxylin-eosin (HE) staining was used to observe the pathological changes in prefrontal cortex and hippocampal CA1, toluidine blue staining was used to detect the neuronal survival in prefrontal cortex and hippocampal CA1, transmission electron microscopy was used to examine neuronal micropathology in prefrontal cortex and hippocampal CA1, and immunofluorescent staining and western blot were used to detect the expression of postsynaptic density protein 95 (PSD95) and synaptophysin (SYN) in hippocampal CA1. Moreover, the changes in gut microbiota were analyzed by 16S rRNA sequencing. The present study found that HLJDD improved the voluntary motor ability and learning memory ability of CAE mice, attenuated prefrontal cortex and hippocampal CA1 damage, and increased the expression of synaptic remodeling-related proteins PSD95 and SYN (P < 0.01), and HLJDD treatment affected the composition of gut microbiota in mice with CAE. HLJDD is an effective traditional Chinese medicine against CAE, and regulating its gut microbiota imbalance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.